130 related articles for article (PubMed ID: 3877764)
1. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii.
Sharma SD; Hofflin JM; Remington JS
J Immunol; 1985 Dec; 135(6):4160-3. PubMed ID: 3877764
[TBL] [Abstract][Full Text] [Related]
2. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
Dannemann BR; Morris VA; Araujo FG; Remington JS
J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
[TBL] [Abstract][Full Text] [Related]
3. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.
Khan IA; Kasper LH
J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333
[TBL] [Abstract][Full Text] [Related]
4. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
5. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
Kasper LH; Matsuura T; Khan IA
J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482
[TBL] [Abstract][Full Text] [Related]
6. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii.
Benedetto N; Auriault C; Darcy F; Lando D; Watier H; Capron A
Eur Cytokine Netw; 1991; 2(2):107-14. PubMed ID: 1813013
[TBL] [Abstract][Full Text] [Related]
7. Protection against lethal toxoplasmosis in mice by an avirulent strain of Toxoplasma gondii: stimulation of IFN-gamma and TNF-alpha response.
Haque S; Franck J; Dumon H; Kasper LH; Haque A
Exp Parasitol; 1999 Dec; 93(4):231-40. PubMed ID: 10600449
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
[TBL] [Abstract][Full Text] [Related]
9. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.
Gazzinelli RT; Wysocka M; Hayashi S; Denkers EY; Hieny S; Caspar P; Trinchieri G; Sher A
J Immunol; 1994 Sep; 153(6):2533-43. PubMed ID: 7915739
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge.
McLeod R; Frenkel JK; Estes RG; Mack DG; Eisenhauer PB; Gibori G
J Immunol; 1988 Mar; 140(5):1632-7. PubMed ID: 3346545
[TBL] [Abstract][Full Text] [Related]
11. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
12. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
13. Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infection.
Weinberg A; Basham TY; Merigan TC
J Immunol; 1986 Nov; 137(10):3310-7. PubMed ID: 3021853
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: effect of sublethal irradiation on host resistance in mice.
Johnson LL; Gibson GW; Sayles PC
Exp Parasitol; 1995 Sep; 81(2):172-81. PubMed ID: 7556559
[TBL] [Abstract][Full Text] [Related]
15. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
Hunter CA; Chizzonite R; Remington JS
J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
[TBL] [Abstract][Full Text] [Related]
16. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
Khan IA; Matsuura T; Fonseka S; Kasper LH
J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815
[TBL] [Abstract][Full Text] [Related]
17. Role of innate immune cells in protection against Toxoplasma gondii at inflamed site.
Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Himeno K
J Med Invest; 2001 Feb; 48(1-2):73-80. PubMed ID: 11286020
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
19. Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection.
Johnson LL; Sayles PC
Nat Immun; 1995 Apr; 14(4):209-15. PubMed ID: 8696010
[TBL] [Abstract][Full Text] [Related]
20. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis.
Hayashi S; Chan CC; Gazzinelli R; Roberge FG
J Immunol; 1996 Feb; 156(4):1476-81. PubMed ID: 8568250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
